PLRX DCF Valuation - Pliant Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 1.21 USD -1.63% Market Closed

Market Cap: $74.9m

	Pliant Therapeutics Inc NASDAQ:PLRX	US
	Site Centers Corp NYSE:SITC	US
N	Nice Ltd TASE:NICE	IL
T	Tokyo Gas Co Ltd TSE:9531	JP
	D'Ieteren Group NV XBRU:DIE	BE
	Mitsubishi Heavy Industries Ltd TSE:7011	JP
T	TriSalus Life Sciences Inc NASDAQ:TLSI	US
	Pilot Corp TSE:7846	JP
	MGIC Investment Corp NYSE:MTG	US
	Hapag Lloyd AG XETRA:HLAG	DE
	Promotora y Operadora de Infraestructura SAB de CV BMV:PINFRA	MX
	ANTA Sports Products Ltd HKEX:2020	CN
	China Minsheng Banking Corp Ltd SSE:600016	CN
O	Osmosun SA PAR:ALWTR	FR
T	Tiger Brands Ltd JSE:TBS	ZA
N	NCR Corp LSE:0K45	US
	Aeva Technologies Inc NYSE:AEVA	US
	Palantir Technologies Inc NASDAQ:PLTR	US
	Liberty Global PLC NASDAQ:LBTYA	UK
E	Evli Oyj OMXH:EVLI	FI

PLRX's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.